Pomalidomide and dexamethasone combination with additional cyclophosphamide in relapsed/refractory multiple myeloma (AMN001)-a trial by the Asian Myeloma Network

• Main Authors: Soekojo, Cinnie Yentia, Kim, Kihyun, Huang, Shang-Yi, Chim, Chor-Sang, Takezako, Naoki, Asaoku, Hideki, Kimura, Hideo, Kosugi, Hiroshi, Sakamoto, Junichi, Gopalakrishnan, Sathish Kumar, Nagarajan, Chandramouli, Wei, Yuan, Moorakonda, Rajesh, Lee, Shu Ling, Lee, Je Jung, Yoon, Sung-Soo, Kim, Jin Seok, Min, Chang Ki, Lee, Jae-Hoon, Durie, Brian, Chng, Wee Joo
• Other Authors: DEAN'S OFFICE (MEDICINE)
• Format: Article
• Language: English
• Published: NATURE PUBLISHING GROUP 2022
• Subjects: Science & Technology; Life Sciences & Biomedicine; Oncology; Hematology; LOW-DOSE DEXAMETHASONE; LENALIDOMIDE; THALIDOMIDE; COHORT
• Online Access: https://scholarbank.nus.edu.sg/handle/10635/229010
• Institution: National University of Singapore

10.1038/s41408-019-0245-1